 New York, New York--Newsfile Corp. - December 9, 2020 - Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the lead plaintiff deadline in a securities class action that has been filed on behalf of investors that purchased or acquired the securities of Reata Pharmaceuticals Inc. NASDAQ: RETA Reata or the Company between October 15, 2019 and August 7, 2020 the Class Period. The lawsuit filed in the United States... 